Member access

4-Traders Homepage  >  Shares  >  Mercado Continuo Espanol  >  FAES Farma SA    FAE   ES0134950F36

FAES FARMA SA (FAE)

6
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Mercado Continuo Espanol
05/20/2015 05/21/2015 05/22/2015 05/25/2015 05/26/2015 Date
2.43(c) 2.435(c) 2.42(c) 2.445(c) 2.42(c) Last
522 131 273 408 131 250 520 156 167 949 Volume
-1.02% +0.21% -0.62% +1.03% -1.02% Change
More quotes
Financials (€)
Sales 2015 202 M
EBIT 2015 37,5 M
Net income 2015 27,3 M
Finance 2015 17,6 M
Yield 2015 2,34%
Sales 2016 212 M
EBIT 2016 45,0 M
Net income 2016 34,0 M
Finance 2016 41,9 M
Yield 2016 2,71%
PER 2015 20,28
PER 2016 17,15
EV / Sales 2015 2,88x
EV / Sales 2016 2,63x
Capitalization 600 M
More Financials
Company
Faes Farma SA engages in the manufacture, marketing, and research of pharmaceutical products and raw materials for pharmaceutical use. Its products are for allergies, antihypertensive, dermatological, diabetes, digestive, otorhinolaryngology, osteoarticular, respiratory, women's health, central... 
Sector
Pharmaceuticals
Calendar
06/22 | 07:00amShareholder meeting
More about the company
Surperformance© ratings of FAES Farma SA
Trading Rating : Investor Rating :
More Ratings
Latest news on FAES FARMA SA
05/18 FAES FARMA : Statement 05/18/2015 (39 k.). Faes Farma has licensed a pharmaceuti..
05/06 FAES FARMA : Comunicado 05/01/2015 (59 k.). Dividendo flexible. Datos de cierre ..
03/02 FAES FARMA : Statement 02/27/2015 (81 k.). Faes Farma increases its net probit b..
2014 FAES FARMA : Statement 05/14/2014 (112 k.). Bilastine in Canada: signing of a li..
2014 FAES FARMA : Statement 05/14/2014 (112 k.). Bilastine in Canada: signing of a li..
2013 FAES FARMA SA : Statement 07/24/2013 (24 k.). January-June results.
2012 FAES FARMA SA : Statement 13/12/2012 (20 k). Faes Farma licences bilastine for S..
2012 FAES FARMA SA : Statement 02/07/2012 (19 k). FAES FARMA S.A. informs of the appr..
More news
Sector news : Pharmaceuticals - NEC
07:08aDJAbbVie Accelerates Share Buybacks After Wrapping Up Pharmacyclics Deal
06:56a MALLINCKRODT : To Present At Goldman Sachs 36th Annual Healthcare Conference
06:36a NOVARTIS : Rani Therapeutics Enters into Agreement with Novartis
More sector news : Pharmaceuticals - NEC


Comments 
Advertisement
Chart FAES FARMA SA
Duration : Period :
FAES Farma SA Technical Analysis Chart | FAE | ES0134950F36 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions